Opportunity Information: Apply for RFA AG 23 015

The National Institutes of Health (NIH) funding opportunity titled "Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed)" (Funding Opportunity Number RFA-AG-23-015; CFDA 93.866) supports basic and mechanistic research focused on how cytosolic DNA and cytosolic DNA-sensing pathways influence the biology of aging. The central theme is that DNA found in the cytosol, whether originating from the nucleus, mitochondria, viruses, or damaged cellular compartments, can trigger innate sensing mechanisms and downstream signaling that may intersect with multiple "hallmarks of aging." NIH is seeking projects that move beyond descriptive observations and instead explain, in detail, the molecular and cellular mechanisms by which cytosolic DNAs shape aging processes, contribute to aging-related decline, or potentially influence longevity and healthspan.

The scientific goal of the FOA is to build an in-depth understanding of how cytosolic DNA sensing mechanisms drive interactions among aging hallmarks. In practice, this means proposals should explore how cytosolic DNA appears, persists, and is detected within cells during aging, and how that detection changes key aging-relevant pathways such as inflammation and immune activation, cellular senescence, genomic instability and DNA damage responses, mitochondrial dysfunction, altered intercellular communication, epigenetic changes, proteostasis stress, stem cell exhaustion, and other widely cited hallmarks. A strong application would typically connect cytosolic DNA sensing to concrete mechanistic links between two or more hallmarks, showing how one hallmark can amplify or suppress another through cytosolic DNA-mediated signaling. The FOA is also explicitly aimed at generating insights that can help address unresolved mechanistic questions about why and how hallmark interactions produce aging phenotypes and aging-related diseases, rather than simply cataloging associations.

This opportunity uses the NIH R01 grant mechanism, indicating support for substantial, multi-year research programs with clearly defined aims, rigorous experimental strategies, and strong justification for feasibility and impact. It is labeled "Clinical Trial Not Allowed," which means the supported work must not include clinical trials as defined by NIH, so the emphasis is on preclinical, mechanistic, and experimental studies (for example, cell-based systems, animal models, human biospecimens analyzed in non-interventional ways, or other translationally relevant approaches that do not meet the NIH definition of a clinical trial). The FOA encourages innovative and mechanistic approaches, which can include development or application of new tools to track cytosolic DNA, dissect sensing pathways, or map downstream signaling consequences that affect healthspan and longevity-related biology.

Eligibility is broad and includes many types of applicant organizations. In addition to standard U.S. academic and research institutions, eligible applicants include state, county, city or township governments, special district governments, independent school districts, federally recognized tribal governments, and tribal organizations that are not federally recognized tribal governments. Eligible entities also include public housing authorities/Indian housing authorities, nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories), private institutions of higher education, for-profit organizations (other than small businesses), and small businesses. The FOA also highlights expanded categories of "other eligible applicants," such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations). This breadth signals NIH interest in attracting diverse scientific perspectives and institutional participation, including from institutions serving underrepresented populations and from international organizations capable of contributing unique expertise.

Key administrative details in the provided source information include that the opportunity is categorized as discretionary funding, uses the grant funding instrument, and falls under the health funding activity category. The original closing date listed is October 11, 2022, and the FOA creation date is February 25, 2022. The award ceiling and expected number of awards are not specified in the excerpt provided, which is common for some NIH announcements where budgets and award counts may depend on application pressure, scientific merit, and available appropriations. Overall, the FOA is designed to fund rigorous, mechanistic aging biology research that clarifies how cytosolic DNA sensing contributes to the interconnected network of aging hallmarks and, ultimately, to the regulation of healthspan and longevity.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2022-02-25.
  • Applicants must submit their applications by 2022-10-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 23 015

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)

Previous opportunity: Bureau of Land Management Alaska Youth Conservation Opportunities on Public Lands

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 23 015

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 23 015) also looked into and applied for these:

Funding Opportunity
Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 012

Funding Number: RFA AG 23 012
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 013

Funding Number: RFA AG 23 013
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 010

Funding Number: RFA AG 23 010
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) Apply for RFA AG 23 011

Funding Number: RFA AG 23 011
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) Apply for PAR 22 128

Funding Number: PAR 22 128
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional) Apply for PAR 22 122

Funding Number: PAR 22 122
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,000,000
The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional) Apply for RFA DE 23 010

Funding Number: RFA DE 23 010
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) Apply for PAR 22 119

Funding Number: PAR 22 119
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R21 Clinical Trial Not Allowed) Apply for RFA DE 23 003

Funding Number: RFA DE 23 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 23 002

Funding Number: RFA DE 23 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) Apply for PAR 22 107

Funding Number: PAR 22 107
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed) Apply for RFA OD 22 003

Funding Number: RFA OD 22 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,800,000
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) Apply for PAR 22 135

Funding Number: PAR 22 135
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional) Apply for RFA OD 22 004

Funding Number: RFA OD 22 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $4,000,000
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 22 022

Funding Number: RFA AI 22 022
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) Apply for PAR 22 118

Funding Number: PAR 22 118
Agency: National Institutes of Health
Category: Health
Funding Amount: $230,000
Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed) Apply for RFA AI 22 019

Funding Number: RFA AI 22 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) Apply for PAR 22 104

Funding Number: PAR 22 104
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
International Bioethics Research Training Program (D43 Clinical Trial Optional) Apply for PAR 22 116

Funding Number: PAR 22 116
Agency: National Institutes of Health
Category: Health
Funding Amount: $230,000
NIA Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 22 130

Funding Number: PAR 22 130
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 23 015", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: